ArticleAnnals of the American Thoracic Society2023
Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.
Abstract read
In one paragraph
Article in Annals of the American Thoracic Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.American journal of respiratory and critical care medicine · 2025Guideline
- Associations of High Attenuation Area-Related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities.American journal of respiratory and critical care medicine · 2025Article
- How Low Can You Go: Exploring the Role of Low-Dose Computed Tomography in Interstitial Lung Disease Detection.Annals of the American Thoracic Society · 2025Article
- Antinuclear antibodies and progression of quantitative interstitial lung changes: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study.Respiratory medicine · 2025Article
- Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study.American journal of respiratory and critical care medicine · 2024Article
- Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.American journal of respiratory and critical care medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
John S KimDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia.ORCID 0000-0002-8887-150X
Sydney B MontesiDivision of Pulmonary and Critical Care Medicine, and.
Ayodeji AdegunsoyeDepartment of Medicine, The University of Chicago Medicine, Chicago, Illinois.ORCID 0000-0002-7015-9610
Stephen M HumphriesDepartment of Radiology, National Jewish Health, Denver, Colorado.ORCID 0000-0002-5113-4530
Margaret L SalisburyDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.ORCID 0000-0001-8217-6955
Lida P HaririDivision of Pulmonary and Critical Care Medicine, and.
Jonathan A KropskiDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.ORCID 0000-0002-8923-1344
Luca RicheldiFondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0001-8594-1448
Athol U WellsDepartment of Radiology, and.
Simon WalshNational Heart and Lung Institute, Imperial College, London, United Kingdom.
R Gisli JenkinsNational Heart and Lung Institute, Imperial College, London, United Kingdom.ORCID 0000-0002-7929-2119
Ivan RosasDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-4622-618X
Imre NothDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of Virginia, Charlottesville, Virginia.ORCID 0000-0001-9846-5030
Gary M HunninghakePulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.ORCID 0000-0001-9782-2841
Fernando J MartinezDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-2412-3182
Anna J PodolanczukDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-9559-1485
Funding
Clinical Genetics and Screening for Pulmonary FibrosisR01HL130974 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GARY MATTHEW HUNNINGHAKE, Benjamin Alexander Raby · 2016 to 2026
$10.0MGenetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung AbnormalitiesR01HL135142 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL H. CHO, GARY MATTHEW HUNNINGHAKE · 2017 to 2026
$7.7MInterstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.R01HL111024 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNNINGHAKE, GARY MATTHEW · 2013 to 2022
$6.4MSpatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosisR01HL145372 · NHLBI · TRANSLATIONAL GENOMICS RESEARCH INST · PI Nicholas Eli Banovich, Jonathan Andrew Kropski · 2019 to 2026
$6.0MIn vivo endobronchial OCT for IPF diagnosis and therapy response assessmentR01HL152075 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HARIRI, LIDA P · 2020 to 2024
$4.0MMechanisms of epithelial repair and remodeling in pulmonary fibrosisR01HL153246 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KROPSKI, JONATHAN ANDREW · 2020 to 2024
$2.8MVascular Leak and Outcomes in IPFK23HL150331 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MONTESI, SYDNEY · 2020 to 2024
$887kRole of High Density Lipoproteins in Interstitial Lung DiseaseK23HL140199 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI PODOLANCZUK, ANNA · 2018 to 2022
$858kRole of polyunsaturated fatty acids in pulmonary fibrosisK23HL150301 · NHLBI · UNIVERSITY OF VIRGINIA · PI KIM, JOHN S · 2021 to 2025
$858kHost Response, Lung Microbiome, and Clinical Phenotype in Hypersensitivity PneumoniaK23HL141539 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SALISBURY, MARGARET LOUISE · 2019 to 2023
$856kImproving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic ClustersK23HL146942 · NHLBI · UNIVERSITY OF CHICAGO · PI ADEGUNSOYE, AYODEJI · 2020 to 2024
$810kDefining the biologic and physiologic trajectory of presymptomatic through advanced pulmonary fibrosisR56HL166941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SALISBURY, MARGARET LOUISE · 2023 to 2023
$768kNHLBI NIH HHS K23 HL140199NHLBI NIH HHS K23HL140199NHLBI NIH HHS K23 HL141539NHLBI NIH HHS K23HL141539NHLBI NIH HHS K23 HL146942NHLBI NIH HHS K23HL146942NHLBI NIH HHS K23 HL150301NHLBI NIH HHS K23HL150301NHLBI NIH HHS K23 HL150331NHLBI NIH HHS K23HL150331NHLBI NIH HHS R01 HL111024NHLBI NIH HHS R01HL111024NHLBI NIH HHS R01 HL130974NHLBI NIH HHS R01HL130974NHLBI NIH HHS R01 HL135142NHLBI NIH HHS R01HL135142NHLBI NIH HHS R01 HL145372NHLBI NIH HHS R01HL145372NHLBI NIH HHS R01 HL152075NHLBI NIH HHS R01HL152075NHLBI NIH HHS R01 HL153246NHLBI NIH HHS R01HL153246NHLBI NIH HHS R56 HL166941
Abstract
PubMed holds no abstract for this paper.
Indexed as
Idiopathic Pulmonary FibrosisPseudomonas InfectionsPulmonary FibrosisAnti-Bacterial AgentsHumansAnti-Bacterial Agents
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.